Trial Profile
To evaluate safety and efficacy of Deferasirox in Single versus divided dosage in Pediatrics thalassemic patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2015
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Thalassaemia
- Focus Therapeutic Use
- 03 Aug 2015 New trial record
- 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.